ALKYL-DIHYDROXYACETONEPHOSPHATE SYNTHASE - FATE IN PEROXISOME BIOGENESIS DISORDERS AND IDENTIFICATION OF THE POINT MUTATION UNDERLYING A SINGLE ENZYME DEFICIENCY
Ecjm. Devet et al., ALKYL-DIHYDROXYACETONEPHOSPHATE SYNTHASE - FATE IN PEROXISOME BIOGENESIS DISORDERS AND IDENTIFICATION OF THE POINT MUTATION UNDERLYING A SINGLE ENZYME DEFICIENCY, The Journal of biological chemistry, 273(17), 1998, pp. 10296-10301
Peroxisomes play an indispensible role in ether lipid biosynthesis as
evidenced by the deficiency of ether phospholipids in fibroblasts and
tissues from patients suffering from a number of peroxisomal disorders
. Alkyl-dihydroxyacetonephosphate synthase, a peroxisomal enzyme playi
ng a key role in the biosynthesis of ether phospholipids, contains the
peroxisomal targeting signal type 2 in a N-terminal cleavable presequ
ence. Using a polyclonal antiserum raised against alkyl-dihydroxyaceto
nephosphate synthase, levels of this enzyme were examined in fibroblas
t cell lines from patients affected by peroxisomal disorders. Strongly
reduced levels were found in fibroblasts of Zellweger syndrome and rh
izomelic chondrodysplasia punctata patients, indicating that the enzym
e is not stable in the cytoplasm as a result of defective import into
peroxisomes, In a neonatal adrenoleukodystrophy patient with an isolat
ed import deficiency of proteins carrying the peroxisomal targeting si
gnal type 1, the precursor form of alkyl-dihydroxyacetonephosphate syn
thase was detected at a level comparable to that of the mature form in
control fibroblasts, in line with an intraperoxisomal localization. A
patient with an isolated deficiency in alkyl-dihydroxyacetonephosphat
e (DHAP) synthase activity had normal levels of this protein. Analysis
at the cDNA level revealed a missense mutation leading to a R419H sub
stitution in the enzyme of this patient. Expression of a recombinant p
rotein carrying this mutation in Escherichia coli yielded an inactive
enzyme, whereas a comparable control recombinant enzyme was active, pr
oviding further proof that this substitution is responsible for the in
activity of the enzyme and the phenotype. In line with this result is
the observation that wild-type alkyl-DHAP synthase activity can be ina
ctivated by the arginine-modifying agent phenylglyoxal, The enzyme is
efficiently protected against this inactivation when the substrate pal
mitoyl-DHAP is present at a saturating concentration. The gene encodin
g human alkyl-dihydroxyacetonephosphate synthase was mapped on chromos
ome 2q31.